TY - ADVS
T1 - Brecht Ingelbeen and Daniel Valia on a community-based antimicrobial stewardship intervention in Burkina Faso and DRC
A2 - Ingelbeen, Brecht
A2 - Valia, Daniel
PY - 2026
Y1 - 2026
N2 - Dr Brecht Ingelbeen and Dr Daniel Valia join Senior Editor Phoebe Hall to discuss a new trial in the journal (the CABU-EICO trial) testing a co-created behavioural intervention bundle to improve antibiotic use, patient management, and water, sanitation and hygiene in rural communities in Burkina Faso and DR Congo.
They explain why the study focused on community prescribing (not hospitals), the primary endpoint was a reduction in WHO AWaRE Watch antibiotics (not overall antibiotics), and the intervention targeted all providers of antibiotics in the community, including informal vendors.
Finally, they discuss the importance of designing an intervention bundle that was truly tailored to local context yet practical, sustainable, and scalable beyond the study sites. A parallel study reporting the effect of the intervention bundle on ESBL-producing Escherichia coli colonisation (a co-primary outcome of the trial) is in press at The Lancet Microbe.
AB - Dr Brecht Ingelbeen and Dr Daniel Valia join Senior Editor Phoebe Hall to discuss a new trial in the journal (the CABU-EICO trial) testing a co-created behavioural intervention bundle to improve antibiotic use, patient management, and water, sanitation and hygiene in rural communities in Burkina Faso and DR Congo.
They explain why the study focused on community prescribing (not hospitals), the primary endpoint was a reduction in WHO AWaRE Watch antibiotics (not overall antibiotics), and the intervention targeted all providers of antibiotics in the community, including informal vendors.
Finally, they discuss the importance of designing an intervention bundle that was truly tailored to local context yet practical, sustainable, and scalable beyond the study sites. A parallel study reporting the effect of the intervention bundle on ESBL-producing Escherichia coli colonisation (a co-primary outcome of the trial) is in press at The Lancet Microbe.
UR - https://open.spotify.com/episode/2PozWo447MjRZqTTksMfKX?si=Hue1dHmsSzaO7eUi3VImsQ&nd=1&dlsi=0c34c082d2e24ce9
UR - https://www.thelancet.com/audio-do/brecht-ingelbeen-and-daniel-valia-community-based-antimicrobial-stewardship
U2 - 10.1016/be37d5f5-cf5d-4312-82af-3974398205f1
DO - 10.1016/be37d5f5-cf5d-4312-82af-3974398205f1
M3 - Audio-visual - Film
PB - Lancet Publishing Group
ER -